Biostatistics Core

生物统计学核心

• 批准号: 10152559
• 负责人: DONNA S. NEUBERG
• 金额: $ 11.75万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-04-25 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10152559
• 关键词: Animals; Basic Science; Biological; Biometry; Biostatistics Core; Cells; Clinical; Clinical Research; Clinical Research Protocols; Conduct Clinical Trials; Correlative Study; Data; Development; Disease; Goals; Human; Laboratories; Laboratory Research; Mus; Mutation; Myeloproliferative disease; New Agents; Outcome; Patients; Reporting; Reproducibility; Resources; Retrospective Studies; Sampling; Techniques; Therapeutic; Work; design; electronic data capture system; experimental study; improved; in vivo; leukemia; next generation sequencing; novel therapeutic intervention; prospective; research study; transcriptome sequencing

Core 2 Biostatisics Project Summary/Abstract The purpose of Core 2 Biostatistics is to provide statistical support to the four Projects as well as to the initiatives involving clinical studies through Core 3 and statistical assessment of biospecimens through Core 1, all toward the goal of development of curative options for patients with AML, MDS, and CMML. This Core assures that the design, conduct, and analyses of all experiments—clinical, correlative, animal, or basic science- -use robust statistical techniques that are appropriately implemented. This central resource thereby helps to elucidate the mechanisms as well as the vulnerabilities of myeloid malignancies.

核心 2 生物统计学项目摘要/摘要 核心 2 生物统计学的目的是为四个项目以及 涉及通过核心 3 进行临床研究和通过核心 1 对生物样本进行统计评估的举措， 一切都是为了为 AML、MDS 和 CMML 患者开发治疗方案。 确保所有实验（临床、相关、动物或基础科学）的设计、实施和分析—— - 使用适当实施的强大统计技术，从而帮助资源。 阐明骨髓恶性肿瘤的机制和脆弱性。